A case report of Wegener granulomatosis treated only with corticosteroids for 30 years

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 1, 2003, Pages 82-85

  PausJenssen, Elizabeth S ^a   Cockcroft, Donald W ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

AGED; ARTHRALGIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; KIDNEY BIOPSY; MEDLINE; PRIORITY JOURNAL; PROGNOSIS; SJOEGREN SYNDROME; SYNOVITIS; SYSTEMIC VASCULITIS; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS;

EID: 0042845887     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62064-9     Document Type: Article

References (15)

1. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76-85.
2. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology. 2001;40:492-498.
3. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996;39:87-92.
4. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
5. Matteson EL, Gold KN, Block DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med. 1996;101:129-134.
6. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995;123:925-932.
7. Galperin C, Hoffman GS. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues. Cleve Clin J Med. 1994;61:416-427.
8. Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual testing conditions. Clin Immunol. 2002;103:196-203.
9. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
10. Rao JK, Allen NB, Feussner JR, Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet. 1995;346:926-931.
11. Langford CA. The diagnostic utility of c-ANCA in Wegener's granulomatosis. Cleve Clin J Med. 1998;65:135-140.
12. Malnick SD, Bass DD, Sthoeger ZM. Letters to the editor. Lancet. 1996;347:117.
13. Gal AA, Velasquez A. Antineutrophil cytoplasmic antibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for a surgical pathologist. Mod Pathol. 2002;15:197-204.
14. Romas E, Murphy BF, d'Apice AJ, Kennedy JT, Niall JF. Wegener's granulomatosis: clinical features and prognosis in 37 patients. Aust N Z J Med. 1993;23:168-175.
15. de Groot K, Reinhold-Keller E, Tatsis E, et al. Therapy for the maintenance of remission in 65 patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum. 1996;39:2052-2061.